Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177919 | SCV000229880 | uncertain significance | not provided | 2014-07-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000177919 | SCV001537392 | uncertain significance | not provided | 2024-04-16 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 36 of the PRPF8 gene. It does not directly change the encoded amino acid sequence of the PRPF8 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs776617795, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This variant has been observed in individual(s) with PRPF8-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 197012). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002485162 | SCV002777522 | uncertain significance | Retinitis pigmentosa 13 | 2021-09-20 | criteria provided, single submitter | clinical testing |